Scilex Holding Company (SCLX)
$5.66-1.22%Close
SELLCRISIS · day 28
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $48M
- Avg volume
- 127.4K
- Beta
- 1.74
- P/E (TTM)
- -0.12
- Short % float
- 2.34%
- Days to cover
- 1.8
- SI change
- -16.1%
- 1W
- -11.56%
- 1M
- -17.25%
- 3M
- +48.95%
- YTD
- -56.76%
- vs SPY 1W
- -10.37%
- vs SPY 1M
- -20.57%
- vs SPY 3M
- +46.56%
- vs SPY YTD
- -68.51%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- BRTXSELLBioRestorative Therapies, Inc.CRISISQ -14$0.21-4.55%
- AEMDSELLAethlon Medical, Inc.CRISISQ -9$2.64-3.30%
- AMRNBUYAmarin Corporation plcRECOVERYQ 2$13.84-1.77%
- CTMXBUYCytomX Therapeutics, Inc.RECOVERYQ 8$3.29+0.30%
- LCTXSELLLineage Cell Therapeutics, Inc.RECOVERYQ 11$1.09+0.93%
- STOKBUYStoke Therapeutics, Inc.RECOVERYQ 13$32.32+0.09%
- TNGXSELLTango Therapeutics, Inc.CRISISQ 24$24.51+2.64%
- TNDMBUYTandem Diabetes Care, Inc.RECOVERYQ -7$22.22-0.45%
- DNTHBUYDianthus Therapeutics, Inc.BULLQ 4$110.07-0.93%
- IMTXSELLImmatics N.V.CRISISQ 8$8.69-2.69%
- GILDBUYGilead Sciences, Inc.RECOVERYQ 23$146.74+0.42%
- HCMBUYHUTCHMED (China) LimitedRECOVERYQ 4$12.18-3.56%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 8
- VALUE
- 3
- GROWTH
- 28
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC114.2%
REV YoY-
ROE190.3%
EPS YoY-
ROA-176.8%
GROSS50
OP-904
NET-1418
[VALUATION]
P/E TTM-0.12
P/E FWD-
SECTOR PE22.66
INDUSTRY PE11.13
P/B-0.13
P/FCF-
EV/EBITDA-0.40
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO0.07
ND/EBITDA-
BETA1.74
